We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Single-cell profiling to transform immunotherapy usage and target discovery in immune-mediated inflammatory diseases.
- Authors
Chapelle, Nicolas; Fantou, Aurelie; Marron, Thomas; Kenigsberg, Ephraim; Merad, Miriam; Martin, Jerome C.
- Abstract
Immunotherapy drugs are transforming the clinical care landscape of major human diseases from cancer, to inflammatory diseases, cardiovascular diseases, neurodegenerative diseases and even aging. In polygenic immunemediated inflammatory diseases (IMIDs), the clinical benefits of immunotherapy have nevertheless remained limited to a subset of patients. Yet the identification of new actionable molecular candidates has remained challenging, and the use of standard of care imaging and/or histological diagnostic assays has failed to stratify potential responders from nonresponders to biotherapies already available. We argue that these limitations partly stem from a poor understanding of disease pathophysiology and insufficient characterization of the roles assumed by candidate targets during disease initiation, progression and treatment. By transforming the resolution and scale of tissue cell mapping, high-resolution profiling strategies offer unprecedented opportunities to the understanding of immunopathogenic events in human IMID lesions. Here we discuss the potential for single-cell technologies to reveal relevant pathogenic cellular programs in IMIDs and to enhance patient stratification to guide biotherapy eligibility and clinical trial design.
- Subjects
IMMUNOTHERAPY; CLINICAL medicine; EXPERIMENTAL design; DRUG discovery; NEURODEGENERATION
- Publication
Frontiers in Immunology, 2022, Vol 13, p1
- ISSN
1664-3224
- Publication type
Article
- DOI
10.3389/fimmu.2022.1006944